Diversified Healthcare Trust Second Quarter 2024 Financial Results and Supplemental Information August 1, 2024 Premier Residences of Plantation 8500 W. Sunrise Blvd. Plantation, FL Exhibit 99.2

Q2 2024 2 FINANCIAL RESULTS Diversified Healthcare Trust Announces Second Quarter 2024 Financial Results ........................................................................................ 3 Second Quarter 2024 Highlights ............................................................................................................................................................................ 4 Second Quarter 2024 Results .................................................................................................................................................................................. 5 FINANCIALS Key Financial Data ..................................................................................................................................................................................................... 6 Condensed Consolidated Balance Sheets ............................................................................................................................................................ 7 Condensed Consolidated Statements of Income (Loss) .................................................................................................................................... 8 Condensed Consolidated Statements of Income (Loss) (Additional Data) ..................................................................................................... 9 DEBT AND LEVERAGE Debt Summary ........................................................................................................................................................................................................... 10 Debt Maturity Schedule ........................................................................................................................................................................................... 11 Leverage Ratios, Coverage Ratios and Bond Covenants ................................................................................................................................... 12 INVESTMENTS Summary of Capital Expenditures .......................................................................................................................................................................... 13 Redevelopment Information .................................................................................................................................................................................... 14 Property Acquisitions / Dispositions Information Since January 1, 2024 ....................................................................................................... 15 Investments in Unconsolidated Joint Ventures .................................................................................................................................................... 16 PORTFOLIO INFORMATION Portfolio Summary by Geographic Diversification and Property Type ........................................................................................................... 18 Portfolio Summary ..................................................................................................................................................................................................... 19 SHOP Units by Operator .......................................................................................................................................................................................... 20 Senior Living NOI by Manager ................................................................................................................................................................................ 21 Senior Living Results of Operations by Location ................................................................................................................................................. 22 Medical Office and Life Science Portfolio and Same Property - Results of Operations .............................................................................. 23 SHOP Segment and Same Property - Results of Operations ............................................................................................................................ 25 SHOP Segment - Five Star and Other Operator Managed Communities Results of Operations .............................................................. 26 Portfolio Leasing Summary ...................................................................................................................................................................................... 27 Tenants Representing 1% or More of Total Annualized Rental Income ......................................................................................................... 28 Medical Office and Life Science Portfolio Lease Expiration Schedule ............................................................................................................ 29 Non-Segment Lease Expiration Schedule ............................................................................................................................................................. 30 APPENDIX Company Profile and Research Coverage ............................................................................................................................................................ 31 Governance Information........................................................................................................................................................................................... 32 Calculation and Reconciliation of NOI and Cash Basis NOI .............................................................................................................................. 33 Calculation and Reconciliation of NOI, Cash Basis NOI, Same Property NOI and Same Property Cash Basis NOI by Segment ....... 34 Calculation and Reconciliation of EBITDA, EBITDAre and Adjusted EBITDAre ............................................................................................ 35 Calculation and Reconciliation of FFO, Normalized FFO and CAD ................................................................................................................. 36 Non-GAAP Financial Measures and Certain Definitions .................................................................................................................................... 38 WARNING CONCERNING FORWARD-LOOKING STATEMENTS ........................................................................................................................................................................ 43 Table of Contents All amounts in this presentation are unaudited. Please refer to Non-GAAP Financial Measures and Certain Definitions for terms used throughout this document. Trading Symbols: Common Shares: DHC Senior Unsecured Notes due 2042: DHCNI Senior Unsecured Notes due 2046: DHCNL Investor Relations Contact: Kevin Brady, Director (617) 796-8234 ir@dhcreit.com Corporate Headquarters: Two Newton Place 255 Washington Street, Suite 300 Newton, MA 02458-1634

Q2 2024 3 "In the second quarter, DHC exceeded expectations for normalized FFO due to revenue growth and expense management. These results were supported by a 27% year over year increase in SHOP same property NOI and occupancy and rent growths. Within our Medical Office and Life Science Portfolio, we achieved a 12% increase in weighted average rental rates on over 100,000 square feet of leasing, which marks our fourth consecutive quarter of double digit rent growth. With continued favorable SHOP industry trends, we are well positioned to execute on our priorities for the remainder of the year. We remain focused on achieving our SHOP NOI growth target for 2024, as well as strengthening our capital and liquidity profile." Christopher Bilotto, President and Chief Executive Officer Diversified Healthcare Trust Announces Second Quarter 2024 Financial Results RETURN TO TABLE OF CONTENTS Newton, MA (August 1, 2024): Diversified Healthcare Trust (Nasdaq: DHC) today announced its financial results for the quarter ended June 30, 2024. Distribution On July 11, 2024, DHC declared a quarterly distribution on its common shares of $0.01 per share to shareholders of record as of the close of business on July 22, 2024. This distribution will be paid on or about August 15, 2024. Conference Call A conference call to discuss DHC's second quarter 2024 financial results will be held on Friday, August 2, 2024 at 1:00 p.m. Eastern Time. The conference call may be accessed by dialing (877) 329-4297 or (412) 317-5435 (if calling from outside the United States and Canada); a pass code is not required. A replay will be available for one week by dialing (877) 344-7529; the replay pass code is 7789230. A live audio webcast of the conference call will also be available in a listen-only mode on DHC's website, at www.dhcreit.com. The archived webcast will be available for replay on DHC's website after the call. The transcription, recording and retransmission in any way of DHC's second quarter conference call are strictly prohibited without the prior written consent of DHC. About Diversified Healthcare Trust DHC is a real estate investment trust, or REIT, focused on owning high-quality healthcare properties located throughout the United States. DHC seeks diversification across the health services spectrum by care delivery and practice type, by scientific research disciplines and by property type and location. As of June 30, 2024, DHC’s approximately $7.2 billion portfolio included 370 properties in 36 states and Washington, D.C., occupied by approximately 500 tenants, and totaling approximately 8.4 million square feet of life science and medical office properties and more than 27,000 senior living units. DHC is managed by The RMR Group (Nasdaq: RMR), a leading U.S. alternative asset management company with over $41 billion in assets under management as of June 30, 2024 and more than 35 years of institutional experience in buying, selling, financing and operating commercial real estate. DHC is headquartered in Newton, MA. For more information, visit www.dhcreit.com.

Q2 2024 4 Financial Results Second Quarter 2024 Highlights RETURN TO TABLE OF CONTENTS Operating Update Liquidity, Financing and Investing Activities • Net loss of $97.9 million, or $0.41 per share. • Normalized FFO of $6.8 million, or $0.03 per share. • Leased 101,047 square feet in DHC's Medical Office and Life Science Portfolio at weighted average rents that were 12.1% higher than prior rents for the same space. • Year over year second quarter SHOP occupancy increased 120 basis points to 79.0% and average monthly rates increased by 6.1%, resulting in an 8.3% increase in SHOP revenues. • Consolidated SHOP NOI increased 17.3% sequentially to $29.0 million, including a margin increase of 140 basis points. • Approximately $270.1 million of cash and cash equivalents and restricted cash. • Executed a $120.0 million CMBS financing, secured by eight properties, which matures in 2034. ◦ $60.0 million of proceeds were used to partially redeem DHC's then outstanding $500.0 million senior unsecured notes due 2025. • Sold one property for $4.2 million in June and two properties for $21.3 million in July. DHC is currently under agreements to sell one property for estimated proceeds of $5.5 million. Same Property Cash Basis NOI For the Three Months Ended (dollars in thousands) June 30, 2024 March 31, 2024 Change June 30, 2023 Change Medical Office and Life Science Portfolio $ 30,784 $ 30,544 0.8 % $ 31,954 (3.7) % SHOP $ 30,378 $ 25,908 17.3 % $ 23,963 26.8 % Consolidated $ 68,817 $ 64,087 7.4 % $ 63,305 8.7 % As of and for the three months ended June 30, 2024, unless otherwise noted

Q2 2024 5 Second Quarter 2024 Results RETURN TO TABLE OF CONTENTS For the Three Months Ended Financial Results June 30, 2024 March 31, 2024 Change June 30, 2023 Change Net loss $ (97,861) $ (86,259) (13.5) % $ (72,571) (34.8) % Net loss per share $ (0.41) $ (0.36) (13.9) % $ (0.30) (36.7) % Normalized FFO $ 6,830 $ 3,523 93.9 % $ 12,133 (43.7) % Normalized FFO per share $ 0.03 $ 0.01 200.0 % $ 0.05 (40.0) % Adjusted EBITDAre $ 68,895 $ 64,060 7.5 % $ 62,136 10.9 % As of and For the Three Months Ended June 30, 2024 March 31, 2024 Basis Point Change June 30, 2023 Basis Point Change Occupancy Medical Office and Life Science Portfolio 81.5% 82.9% (140) 85.8% (430) SHOP 79.0% 78.9% 10 77.8% 120 Same Property Occupancy Medical Office and Life Science Portfolio 87.4% 90.1% (270) 94.0% (660) SHOP 79.6% 79.4% 20 78.0% 160 (dollars in thousands, except per share data)

Q2 2024 6 Key Financial Data RETURN TO TABLE OF CONTENTS As of and For the Three Months Ended 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 Selected Balance Sheet Data: Total gross assets $ 7,440,385 $ 7,410,364 $ 7,466,979 $ 7,496,204 $ 7,493,885 Total assets $ 5,333,447 $ 5,348,037 $ 5,446,136 $ 5,530,256 $ 5,585,475 Total liabilities $ 3,184,133 $ 3,099,334 $ 3,109,245 $ 3,088,730 $ 3,076,086 Total equity $ 2,149,314 $ 2,248,703 $ 2,336,891 $ 2,441,526 $ 2,509,389 Selected Income Statement Data: Total revenues $ 371,392 $ 370,776 $ 361,535 $ 356,524 $ 346,219 Net loss $ (97,861) $ (86,259) $ (102,564) $ (65,779) $ (72,571) NOI $ 67,327 $ 63,172 $ 58,124 $ 58,092 $ 59,991 Adjusted EBITDAre $ 68,895 $ 64,060 $ 59,189 $ 58,809 $ 62,136 FFO $ 14,563 $ 2,588 $ 5,645 $ 4,670 $ 6,090 Normalized FFO $ 6,830 $ 3,523 $ 8,079 $ 8,346 $ 12,133 CAD $ (5,766) $ 2,411 $ (45,006) $ (33,586) $ (13,317) Rolling four quarter CAD $ (81,947) $ (89,498) $ (112,582) $ (114,165) $ (127,839) Per Share Data (basic and diluted): Net loss $ (0.41) $ (0.36) $ (0.43) $ (0.28) $ (0.30) FFO $ 0.06 $ 0.01 $ 0.02 $ 0.02 $ 0.03 Normalized FFO $ 0.03 $ 0.01 $ 0.03 $ 0.03 $ 0.05 CAD $ (0.02) $ 0.01 $ (0.19) $ (0.14) $ (0.06) Rolling four quarter CAD $ (0.34) $ (0.38) $ (0.48) $ (0.49) $ (0.55) Dividends: Annualized dividend declared per common share $ 0.04 $ 0.04 $ 0.04 $ 0.04 $ 0.04 Annualized dividend yield (at end of period) 1.3 % 1.6 % 1.1 % 2.1 % 1.8 % Normalized FFO payout ratio 33.3 % 100.0 % 33.3 % 33.3 % 20.0 % CAD payout ratio (50.0) % 100.0 % (5.3) % (7.1) % (16.7) % Rolling four quarter CAD payout ratio (11.8) % (10.5) % (8.3) % (8.2) % (7.3) % (dollars in thousands, except per share data) Morningside of Charlottesville 491 Crestwood Drive Charlottesville, VA

Q2 2024 7 June 30, 2024 December 31, 2023 Assets Real estate properties: Land $ 635,792 $ 652,977 Buildings and improvements 6,126,130 6,165,490 Total real estate properties, gross 6,761,922 6,818,467 Accumulated depreciation (2,106,938) (2,020,843) Total real estate properties, net 4,654,984 4,797,624 Investments in unconsolidated joint ventures 108,806 129,916 Assets of properties held for sale 43,969 9,447 Cash and cash equivalents 265,563 245,939 Restricted cash 4,522 1,022 Equity method investment 24,905 — Acquired real estate leases and other intangible assets, net 29,658 33,948 Other assets, net 201,040 228,240 Total assets $ 5,333,447 $ 5,446,136 Liabilities and Shareholders' Equity Senior secured notes, net $ 776,262 $ 731,211 Senior unsecured notes, net 2,015,093 2,072,618 Secured debt and finance leases, net 128,560 13,020 Liabilities of properties held for sale 581 32 Accrued interest 23,227 22,847 Other liabilities 240,410 269,517 Total liabilities 3,184,133 3,109,245 Commitments and contingencies Shareholders' equity: Common shares of beneficial interest, $.01 par value: 300,000,000 shares authorized, 240,619,470 and 240,423,898 shares issued and outstanding, respectively 2,406 2,405 Additional paid in capital 4,619,846 4,618,470 Cumulative net income 1,594,158 1,778,278 Cumulative other comprehensive loss (26) — Cumulative distributions (4,067,070) (4,062,262) Total shareholders' equity 2,149,314 2,336,891 Total liabilities and shareholders' equity $ 5,333,447 $ 5,446,136 Condensed Consolidated Balance Sheets (dollars in thousands, except share data) RETURN TO TABLE OF CONTENTS 4 Maguire Road Lexington, MA

Q2 2024 8 For the Three Months Ended June 30, For the Six Months Ended June 30, 2024 2023 2024 2023 Revenues: Rental income $ 62,870 $ 61,373 $ 125,520 $ 127,811 Residents fees and services 308,522 284,846 616,648 564,438 Total revenues 371,392 346,219 742,168 692,249 Expenses: Property operating expenses 304,065 286,228 611,669 572,308 Depreciation and amortization 68,357 68,394 138,490 133,194 General and administrative 6,262 7,284 13,830 13,157 Acquisition and certain other transaction related costs 1,826 6,043 1,912 6,136 Impairment of assets 6,545 11,299 18,687 17,224 Total expenses 387,055 379,248 784,588 742,019 (Loss) gain on sale of properties (13,213) — (19,087) 1,233 Gains and losses on equity securities, net — — — 8,126 Interest and other income 2,403 5,134 4,640 9,329 Interest expense (including net amortization of debt discounts, premiums and issuance costs of $25,591, $2,249, $50,454 and $4,323, respectively) (58,702) (47,384) (116,278) (95,164) Loss on modification or early extinguishment of debt (209) — (209) (1,075) Loss before income tax expense and equity in net (losses) earnings of investees (85,384) (75,279) (173,354) (127,321) Income tax expense (170) (221) (357) (190) Equity in net (losses) earnings of investees (12,307) 2,929 (10,409) 2,282 Net loss $ (97,861) $ (72,571) $ (184,120) $ (125,229) Weighted average common shares outstanding (basic and diluted) 239,326 238,682 239,259 238,636 Per common share data (basic and diluted): Net loss $ (0.41) $ (0.30) $ (0.77) $ (0.52) Condensed Consolidated Statements of Income (Loss) RETURN TO TABLE OF CONTENTS (amounts in thousands, except per share data) The Remington Club 16925 Hierba Drive San Diego, CA

Q2 2024 9 For the Three Months Ended June 30, For the Six Months Ended June 30, 2024 2023 2024 2023 Additional Data: General and administrative expenses / total assets (at end of period) 0.1 % 0.1 % 0.3 % 0.2 % Business management incentive fees included in general and administrative expenses $ (849) $ — $ — $ — Non-cash straight line rent adjustments included in rental income $ 656 $ (4,457) $ 947 $ (2,009) Lease value amortization included in rental income $ (29) $ (25) $ (57) $ 286 Lease termination fees included in rental income $ — $ 2,183 $ 203 $ 2,487 Non-cash share based compensation $ 940 $ 565 $ 1,498 $ 834 Non-cash amortization included in property operating expenses $ 199 $ 199 $ 398 $ 398 Non-cash amortization included in general and administrative expenses $ 743 $ 743 $ 1,487 $ 1,487 Condensed Consolidated Statements of Income (Loss) (Additional Data) (dollars in thousands) RETURN TO TABLE OF CONTENTS

Q2 2024 10 Coupon Interest Principal Maturity Due at Years to Rate Rate Balance Date Maturity Maturity Unsecured Fixed Rate Debt: Senior unsecured notes due 2025 (1) (2) 9.750% 9.750% $ 440,000 6/15/2025 $ 440,000 1.0 Senior unsecured notes due 2028 4.750% 4.966% 500,000 2/15/2028 500,000 3.6 Senior unsecured notes due 2031 (2) 4.375% 4.375% 500,000 3/1/2031 500,000 6.7 Senior unsecured notes due 2042 5.625% 5.625% 350,000 8/1/2042 350,000 18.1 Senior unsecured notes due 2046 6.250% 6.250% 250,000 2/1/2046 250,000 21.6 Weighted average rate / total unsecured fixed rate debt 6.070% 6.123% 2,040,000 2,040,000 8.5 Secured Fixed Rate Debt: Senior secured notes due 2026 (2) (3) (4) (5) 0.000% 0.000% 940,534 1/15/2026 940,534 1.5 Finance leases - 2 properties 7.700% 7.700% 3,140 4/30/2026 155 1.8 Mortgage - secured by eight properties (6) 6.864% 6.864% 120,000 6/11/2034 120,000 10.0 Mortgage - secured by one property 6.444% 6.444% 8,294 7/6/2043 70 19.0 Weighted average rate / total secured fixed rate debt 0.841% 0.841% 1,071,968 1,060,759 1.3 Weighted average rate / total debt 4.269% 4.304% $ 3,111,968 $ 3,100,759 6.0 Debt Summary (dollars and sq. ft. in thousands) RETURN TO TABLE OF CONTENTS As of June 30, 2024 (1) DHC has the option to redeem all or a portion of its senior unsecured notes due 2025 at any time at a set redemption price, which, as of June 15, 2024, equaled 100% of the principal amount to be redeemed. (2) As of June 30, 2024, all of DHC's senior unsecured notes due 2025 and senior unsecured notes due 2031 were fully and unconditionally guaranteed, on a joint, several and senior unsecured basis, by all of DHC's subsidiaries except certain excluded subsidiaries, and all of DHC's senior secured notes due 2026 were fully and unconditionally guaranteed, on a joint, several and senior secured basis, by certain of DHC's subsidiaries, and on a joint, several and unsecured basis, by DHC's other subsidiaries, except for certain excluded subsidiaries. The senior secured notes and the related guarantees on a senior secured basis are secured by a first priority lien and security interest in each of the collateral properties and 100% of the equity interests in each of the collateral guarantors. The notes and the guarantees (other than the senior secured notes and the related guarantees on a senior secured basis) are effectively subordinated to all of DHC's and the subsidiary guarantors' secured indebtedness, respectively, to the extent of the value of the applicable collateral, and the notes and the related guarantees are structurally subordinated to all indebtedness and other liabilities and any preferred equity of DHC's subsidiaries that do not guarantee the notes. (3) No cash interest will accrue on these senior secured notes prior to maturity. The accreted value of these senior secured notes will increase at a rate of 11.25% per annum compounded semiannually on January 15 and July 15 of each year, such that the accreted value will equal the principal amount at maturity. (4) Summary information of the properties securing these senior notes are as follows as of June 30, 2024: • Properties: 95 (63 Medical Office/Life Science; 22 triple net leased senior living; 10 triple net leased wellness centers) • Sq. Ft. / Units: 5,788 sq. ft. / 1,529 units • Q2 2024 NOI: $27,571 • Gross book value of real estate assets: $1,611,517 • Occupancy (Medical Office and Life Science Portfolio): 90.1% • Rent coverage (triple net senior living and wellness centers): 1.86x • Weighted average lease term: 6.8 years (5) DHC has a one-time option to extend the maturity date of these senior secured notes by one year, to January 15, 2027, subject to satisfaction of certain conditions and payment of an extension fee. If DHC exercises this option, interest payments will be due semiannually during the extension period at an initial interest rate of 11.25% with increases of 50 basis points every 90 days these senior secured notes remain outstanding. (6) In May 2024, DHC executed a $120.0 million fixed rate, interest only mortgage loan secured by eight properties.

Q2 2024 11 $440,000 $500,000 $500,000 $600,000 $600 $1,971 $941,412 $280 $299 $319 $340 $363 $387 $125,997 Unsecured Fixed Rate Debt Secured Fixed Rate Debt 2024 2025 2026 2027 2028 2029 2030 2031 2032 Thereafter $0 $200,000 $400,000 $600,000 $800,000 $1,000,000 Debt Maturity Schedule (1) RETURN TO TABLE OF CONTENTS (dollars in thousands) As of June 30, 2024 (1) Includes $3,140 of finance lease obligations due through April 2026. (2) DHC has a one-time option to extend the maturity date of its $940,534 senior secured notes due 2026 by one year, to January 15, 2027, subject to satisfaction of certain conditions and payment of an extension fee. If DHC exercises this option, interest payments will be due semiannually during the extension period at an initial interest rate of 11.25% with increases of 50 basis points every 90 days these senior secured notes remain outstanding. (2)

Q2 2024 12 Leverage Ratios, Coverage Ratios and Bond Covenants RETURN TO TABLE OF CONTENTS As of and For the Three Months Ended 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 Leverage Ratios: Net debt / total gross assets 38.3% 38.4% 37.6% 33.8% 32.8% Net debt / gross book value of real estate assets 39.5% 39.5% 38.9% 35.3% 34.5% Secured debt / total assets 20.1% 17.8% 17.5% 8.4% 8.3% Variable rate debt / net debt —% —% —% 17.7% 18.3% Coverage Ratios: Net debt / annualized Adjusted EBITDAre 10.2x 10.8x 12.3x 10.6x 9.8x Adjusted EBITDAre / interest expense 1.2x 1.1x 1.2x 1.2x 1.3x As of and For the Trailing Twelve Months Ended 6/30/2024 3/31/2023 12/31/2023 9/30/2023 6/30/2023 Bond Covenants: Maintenance Covenant Total unencumbered assets / unsecured debt - required minimum 150.0% 267.5% 271.2% 274.5% 261.4% 264.4% Incurrence Covenants Total debt / adjusted total assets - allowable maximum 60.0% 41.2% 40.6% 40.3% 37.0% 37.0% Secured debt / adjusted total assets - allowable maximum 40.0% 14.2% 12.7% 12.6% 6.1% 6.1% Consolidated income available for debt service / debt service - required minimum 1.50x (1)(2) 1.76x 1.64x 1.64x 1.17x 1.08x 1145 19th Street NW Washington, D.C. (1) As of June 30, 2024, DHC's ratio of consolidated income available for debt service to debt service is presented on a pro forma basis to reflect the proceeds from the $120.0 million mortgage loan executed in May 2024 with a maturity date in June 2034. DHC used $60.0 million of net proceeds from this loan to partially redeem its then outstanding $500.0 million senior notes due 2025. (2) Beginning with the December 31, 2023 period, DHC's ratio of consolidated income available for debt service to debt service is presented on a pro forma basis to reflect the proceeds from the issuance of $940.5 million of zero coupon senior secured notes due 2026. DHC used the net proceeds from this issuance to repay in full its then existing $450.0 million secured credit facility and to redeem $250.0 million of its senior notes due 2024.